LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
873
via finance.yahoo.comBusiness & Companies

Amgen beats estimates but shares dip on biosimilar concerns

FROM THE WIRE · FINANCE.YAHOO.COM

Investing.com -- Amgen Inc (NASDAQ:AMGN) reported third quarter results that exceeded Wall Street expectations, but shares fell 1.5% in after-hours trading Tuesday as investors weighed the impact of biosimilar competition on key products. Still guessing which stocks will beat…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishEarnings beat expectations, but shares fell after hours on biosimilar competition for key products.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Amgen reported adjusted EPS of $6.45 versus $5.76 consensus.
  2. 02Revenue rose 8% year over year to $10.4 billion, above the $10.06 billion estimate.
  3. 03Biosimilar concerns for Prolia and XGEVA overshadowed the results.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.